Deflazacort Oral Suspension
Product Images NDC 70710-2007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Deflazacort Oral Suspension (NDC 70710-2007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 01)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 02)

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 02)
This text appears to be a description of a medication called Deflazacort in oral suspension form. It mentions a bottle adapter and a household cup for measurement. It seems to be a preparation guide for using the medication.*
FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 03)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 04)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 05)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 06)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 07)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 08)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 09)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 10)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 11)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 12)

FDA Label Image

Image (Fa15a687 0c62 4bc4 B377 90a303d19b12 13)

FDA Label Image

Container (Fa15a687 0c62 4bc4 B377 90a303d19b12 14)

Container (Fa15a687 0c62 4bc4 B377 90a303d19b12 14)
This text provides information about an oral medication called Deflazacort. Each milliliter contains 22.75 mg of deflazacort. The package is child-resistant. The dosage and administration details are available in the package insert. It is recommended to keep the medication out of reach of children and store it at a temperature range of 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be stored tightly closed after opening. The product is manufactured by Doppel Farmaceutici s.r.l. in Milan, Italy, and distributed by Zydus Pharmaceuticals (USA) Inc. located in Pennington, New Jersey. This medication is available by prescription only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.